《新股消息》JS环球生活(01691.HK)定价5.2元 一手中签率100%
小型家电商JS环球生活(01691.HK)公布招股结果,每股以5.2元定价,一手500股中签率100%。该股将於明日(18日)挂牌,联席保荐人为瑞信、摩根士丹利及工银国际。
该股公开发售部分获超额认购1.68倍,国际配售获适度超额认购。公司预计集资净额为23.897亿元,当中约50%将用於部分偿还一笔来自商业银行的定期贷款(供股息分派,本金额为4.7亿美元);约20%将用於研发新产品及进一步整合及开发供应链;约20%将用於全球的市场开发及扩展以及提升品牌形象及知名度;及约10%将用於营运资金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.